Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
AdvaMed states that the huge tax increase will have a significant impact on employment and investment.
Stakeholders warn that more EtO facility closures could have a catastrophic result.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
“We don’t know how long the shutdown is going to continue,” says the association’s President and CEO Scott Whitaker.
Device companies will need to assess their business model in order to compete in an outcomes-based reimbursement environment.
The Senate vote is good news for industry, which has fought against the tax for years.
With an established base of medtech companies and a strong workforce, Ireland remains a key player in the global supply chain.
Expect to see slow growth and more mergers & acquisitions.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.